These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 20007431

  • 1. Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid.
    Mellergård J, Edström M, Vrethem M, Ernerudh J, Dahle C.
    Mult Scler; 2010 Feb; 16(2):208-17. PubMed ID: 20007431
    [Abstract] [Full Text] [Related]

  • 2. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis.
    Ishizu T, Osoegawa M, Mei FJ, Kikuchi H, Tanaka M, Takakura Y, Minohara M, Murai H, Mihara F, Taniwaki T, Kira J.
    Brain; 2005 May; 128(Pt 5):988-1002. PubMed ID: 15743872
    [Abstract] [Full Text] [Related]

  • 3. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
    Moreira MA, Tilbery CP, Monteiro LP, Teixeira MM, Teixeira AL.
    Acta Neurol Scand; 2006 Aug; 114(2):109-13. PubMed ID: 16867033
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CSF cytokine and chemokine profiles in acute disseminated encephalomyelitis.
    Ishizu T, Minohara M, Ichiyama T, Kira R, Tanaka M, Osoegawa M, Hara T, Furukawa S, Kira J.
    J Neuroimmunol; 2006 Jun; 175(1-2):52-8. PubMed ID: 16697050
    [Abstract] [Full Text] [Related]

  • 8. CCL5, CXCL10 and CXCL11 chemokines in patients with active and stable relapsing-remitting multiple sclerosis.
    Szczuciński A, Losy J.
    Neuroimmunomodulation; 2011 Jun; 18(1):67-72. PubMed ID: 20720435
    [Abstract] [Full Text] [Related]

  • 9. Cord blood cytokines and chemokines and development of allergic disease.
    Sandberg M, Frykman A, Ernerudh J, Berg G, Matthiesen L, Ekerfelt C, Nilsson LJ, Jenmalm MC.
    Pediatr Allergy Immunol; 2009 Sep; 20(6):519-27. PubMed ID: 19175890
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-8 and RANTES levels in patients with relapsing-remitting multiple sclerosis (RR-MS) treated with cladribine.
    Bartosik-Psujek H, Belniak E, Mitosek-Szewczyk K, Dobosz B, Stelmasiak Z.
    Acta Neurol Scand; 2004 Jun; 109(6):390-2. PubMed ID: 15147461
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing-remitting multiple sclerosis patients.
    Kalinowska-Łyszczarz A, Szczuciński A, Pawlak MA, Losy J.
    J Neurol Sci; 2011 Jan 15; 300(1-2):81-5. PubMed ID: 20947098
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.
    Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, Lit LC, Hui DS, Chan MH, Chung SS, Sung JJ.
    Clin Exp Immunol; 2004 Apr 15; 136(1):95-103. PubMed ID: 15030519
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.
    Kerr JR, Cunniffe VS, Kelleher P, Coats AJ, Mattey DL.
    J Med Virol; 2004 Sep 15; 74(1):147-55. PubMed ID: 15258981
    [Abstract] [Full Text] [Related]

  • 17. Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF.
    Mei FJ, Ishizu T, Murai H, Osoegawa M, Minohara M, Zhang KN, Kira J.
    J Neurol Sci; 2005 Jan 15; 228(1):75-85. PubMed ID: 15607214
    [Abstract] [Full Text] [Related]

  • 18. A link between chemokine levels and disease severity in human African trypanosomiasis.
    Courtioux B, Boda C, Vatunga G, Pervieux L, Josenando T, M'Eyi PM, Bouteille B, Jauberteau-Marchan MO, Bisser S.
    Int J Parasitol; 2006 Aug 15; 36(9):1057-65. PubMed ID: 16765963
    [Abstract] [Full Text] [Related]

  • 19. Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment.
    Wipfler P, Oppermann K, Pilz G, Afazel S, Haschke-Becher E, Harrer A, Huemer M, Kunz A, Golaszewski S, Staffen W, Ladurner G, Kraus J.
    Mult Scler; 2011 Jan 15; 17(1):16-23. PubMed ID: 20937631
    [Abstract] [Full Text] [Related]

  • 20. Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis.
    Stüve O, Cepok S, Elias B, Saleh A, Hartung HP, Hemmer B, Kieseier BC.
    Arch Neurol; 2005 Oct 15; 62(10):1620-3. PubMed ID: 16216948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.